Keen v. Merck Sharp & Dohme Corp

CourtDistrict Court, N.D. Illinois
DecidedApril 15, 2019
Docket1:15-cv-01178
StatusUnknown

This text of Keen v. Merck Sharp & Dohme Corp (Keen v. Merck Sharp & Dohme Corp) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Keen v. Merck Sharp & Dohme Corp, (N.D. Ill. 2019).

Opinion

IN THE UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

JOYCE KEEN, ) ) Plaintiff, ) ) ) No. 15-cv-1178 v. ) ) Judge Sharon Johnson Coleman MERCK SHARP & DOHME CORP., ) a foreign corporation, ) ) Defendant. )

MEMORANDUM OPINION AND ORDER This matter comes before the Court on plaintiff Joyce Keen’s motion to vacate the summary judgment ruling in favor of defendant Merck Sharp & Dohme Corporation’s (“Merck”) and hold Merck and Respondents Wheels, Inc. (“Wheels”) and Michael Wells in contempt of Court. Respondents brought their own motions for proof of service and attorney’s fees. This Court has reviewed the parties’ extensive submissions, including pre-hearing briefs, and held a two day hearing on January 16–17, 2019. For the reasons stated herein, this Court denies Keen’s Motion to Vacate Summary Judgment [187] and Motion for Rule to Show Cause [189]. The Court dismisses Respondents’ Motion to Compel Plaintiff to Produce Proof of Service of the Subpoena [197] as moot and denies Respondents’ Motion for Attorney’s Fees [233]. Background Plaintiff, Joyce Keen, filed a seven count First Amended Complaint, alleging disability discrimination and failure to accommodate, gender discrimination, and retaliation. The Court granted Merck’s motion for summary judgment on all counts on March 5, 2018. (Dkt. 174.) The Court assumes familiarity with the factual record detailed in its summary judgment order. Keen filed her appeal of the Court’s order on March 26, 2018. (Dkt. 179.) Keen contacted Merck Human Resources Business Partner Kristen Frank in May 2018 regarding questions concerning income related to personal use of her company vehicle reflected on her W2 tax form. James Jin (another Merck employee) contacted Wheels, and Wheels provided Jin with reported mileage and excerpts of Wheels’ call logs that listed phone calls that Keen made to

Wheels. Wheels is the fleet management company that handled certain aspects of Merck’s company vehicle program. On June 6, 2018, Frank responded to Keen and included portions of the call log that Wheels maintained. (Dkt. 189-1, Ex. C.) Among those call log excerpts were entries regarding Keen’s questions concerning her company vehicle serviced by Wheels. Frank testified that she did not have those excerpts of the call log entries prior to Keen’s questions and that she did not have direct access to the Wheels’ information regarding employee cars, including any call logs, or other Wheels records. Further, Frank was unaware of any Merck employees who have direct access into Wheel’s call log records. On September 17, 2018, Keen filed her motion to vacate summary judgment and motion to hold Merck, Wheels, and Wells in contempt of court. Respondents filed their motion for Keen to produce proof of service of the subpoena and a motion for attorney’s fees on October 2, 2018 and January 7, 2019, respectively. In December 2018, Wheels produced documents in response to the subpoena riders directed to Michael Wells, Kim Baskerville, and Fabiola Gonzalez in conjunction

with the January evidentiary hearing. The production included emails between Keen and Wheels employees and internal emails between Wheels employees. Pending an evidentiary hearing on Keen’s motions, the Seventh Circuit retained jurisdiction over the appeal and suspended briefing until this Court ruled on the motion for relief from judgment. (Dkt. 199.) At the hearing, several of Wheels’ employees testified regarding the interaction of Wheels’ and Merck’s systems. Erika Smith, formerly a Driver Services Associate employed by Wheels, worked in the Wheels’ call center and took calls directly from drivers, including from Keen. She testified that when she received a medical exception request, she would consult the Merck profile to view its decision. Wheels would apply the instructions provided by Merck because Wheels had no authority regarding whether to grant medical exception requests. (See also Wheels Ex. 77.) Smith

explained that her notes regarding her calls with Keen reflected what Keen said to her, and do not reflect any sort of recommendation or suggestion from Smith. Further, Smith testified that she was not trained to make medical exception decisions, and she was not aware of any individuals at Wheels who were qualified to make those kinds of assessments. Wheels Account Executive Kim Baskerville testified that she served as the liaison between driver services at Wheels and Merck, which meant that she sometimes would receive requests for specific vehicles from drivers. She monitored a Wheels email account (Merck.admin@wheels.com) that was dedicated to Merck vehicle requests. Baskerville explained that although she had some communications with Keen, she does not have input into medical exception decisions and does not have access to Merck’s systems. Rather, all medical exception vehicle requests are directly handled by Merck. Baskerville testified that no one at Wheels had any role in deciding whether to grant a medical exception vehicle and that no one ever asked her input on whether an exception should be granted for Keen.

Wheels Driver Care Operations Associate Fabiola Gonzalez testified that her name is listed on the requests received from Keen because Gonzalez would distribute requests received in the call center to the appropriate Wheels account executive. (Pl. Ex. 21.) Gonzalez also had no decision making authority regarding the final response to a request, which includes medical exception vehicle decisions, recommendations, or suggestions. The parties also presented testimony regarding the documents produced in the litigation. First, Michael Wells, who has held the role of Risk Management Coordinator at Wheels for approximately five years, testified regarding Keen’s subpoenas to Wheels. Although Wells did not recall the specifics about how he received it from Keen, he received a subpoena in late November or December 2016, which requested documents and data regarding Keen and her request for a vehicle. (Pl. Ex. 7.) Wells testified that he called Keen’s attorney to figure out what kind of documents he

was looking for. Then Wells sent Keen’s attorney the vehicle’s title and service history and asked Keen’s attorney to let him know if he needed anything else. Keen’s attorney never responded except to request unredacted versions of the records, which Wells provided. Wells testified that he did not withhold any records that Keen’s counsel specifically asked him to produce and that he did not conceal any records from Keen. Further, Wells testified that he received an email that included an offer to assist with responding to the subpoena from Merck’s counsel, but he did not communicate with Merck’s counsel and no one from Merck’s counsel’s law firm or within the Wheels’ organization asked him to withhold or conceal any records. Keen’s supervisor at Merck, David Hass, testified regarding the documents that he turned over for production in the litigation. Specifically, Hass stated that he provided thousands of emails to Merck’s counsel when requested earlier in litigation and that he did not have anything additional to provide counsel in response to the hearing subpoena. (Dkt. 210-3.) Another Merck manager, Robert Church, also submit an affidavit stating that he provided all relevant emails earlier in the

litigation, as requested. (Dkt. 210-4.) Hass further testified that he was not involved in the decision to deny Keen’s medical exception vehicle request. Rather, Merck’s Health Services Department makes decisions regarding these vehicle requests. Finally, Keen testified regarding a number of exhibits that she stated Wheels did not produce until 2018 after Keen subpoenaed the documents a second time. Keen recognized that her email was included on at least some of the emails that she testified were not produced by Merck or Wheels during the case.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Chambers v. Nasco, Inc.
501 U.S. 32 (Supreme Court, 1991)
Wickens v. Shell Oil Co.
620 F.3d 747 (Seventh Circuit, 2010)
Howard Kiburz v. Secretary Navy
446 F. App'x 434 (Third Circuit, 2011)
Harry F. Chaveriat, Jr. v. Williams Pipe Line Company
11 F.3d 1420 (Seventh Circuit, 1993)
Chaunte Ott v. City of Milwaukee
682 F.3d 552 (Seventh Circuit, 2012)
Michael A. Willis v. William J. Lep
687 F.3d 826 (Seventh Circuit, 2012)
Jeremy Venson v. Lazaro Altamirano
749 F.3d 641 (Seventh Circuit, 2014)
In re Rosen
542 B.R. 177 (E.D. Pennsylvania, 2015)
Hecht v. Don Mowry Flexo Parts, Inc.
111 F.R.D. 6 (N.D. Illinois, 1986)

Cite This Page — Counsel Stack

Bluebook (online)
Keen v. Merck Sharp & Dohme Corp, Counsel Stack Legal Research, https://law.counselstack.com/opinion/keen-v-merck-sharp-dohme-corp-ilnd-2019.